Kenna Mills Shaw, Ph.D.

Executive Director, Institute for Personalized Cancer Therapy at MD Anderson Cancer Center

As the Executive Director of the Institute for Personalized Cancer Therapy at MD Anderson, Dr. Kenna Mills Shaw leads and oversees the development and growth of the Institute for Personalized Cancer Therapy including collaborative opportunities with the pharmaceutical industry, as well as with not-for-profit organizations. Prior to joining MD Anderson, she was Director of The Cancer Genome Atlas Program office at the National Cancer Institute. Dr. Shaw earned a Ph.D in cell and developmental biology from Harvard University and completed her postdoctoral training at the National Institutes of Child Health and Development.